Document Detail


Hematopoietic stem cell transplantation for the treatment of autoimmunity in type 1 diabetes.
MedLine Citation:
PMID:  20955158     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Type 1 diabetes (T1D) is an autoimmune disease that leads to the destruction of the insulin-producing pancreatic b cells. While there is no current cure, recent work in the field of allogeneic hematopoietic stem cell transplantation (HSCT) and the induction of mixed chimerism, a state in which multilineage hematopoietic populations of both recipient and donor co-exist, has demonstrated that it is possible to provide protection from disease onset, as well as reverse the autoimmune state in spontaneously diabetic mice. Furthermore, the establishment of mixed chimerism induces donor-specific tolerance, providing the potential to normalize glucose regulation via pancreatic islet transplantation without the requirement of life-long immunosuppression. Current studies are aimed at understanding the mechanisms involved in both the reversal of autoimmunity and the induction of tolerance, with the aim of moving this promising approach to curing T1D into the clinic.
Authors:
Samuel A LoCascio; Joia Spinelli; Josef Kurtz
Related Documents :
11900278 - The non-immune rip-kb mouse is a useful host for islet transplantation, as the diabetes...
15591438 - Antigen-specific foxp3-transduced t-cells can control established type 1 diabetes.
17303808 - Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in nod mice.
11943868 - Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosin...
171948 - Atypical adrenal insufficiency with failure of the pituitary feedback receptor. a case ...
9706068 - Response to ten generations of divergent selection for tibial dyschondroplasia in broil...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current stem cell research & therapy     Volume:  6     ISSN:  1574-888X     ISO Abbreviation:  Curr Stem Cell Res Ther     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-11     Completed Date:  2011-05-20     Revised Date:  2012-01-19    
Medline Journal Info:
Nlm Unique ID:  101272517     Medline TA:  Curr Stem Cell Res Ther     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  29-37     Citation Subset:  IM    
Affiliation:
Emmanuel College, Boston, Massachusetts 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Autoantigens / immunology
Autoimmunity*
Diabetes Mellitus, Experimental / surgery
Diabetes Mellitus, Type 1 / immunology,  pathology,  therapy*
Hematopoietic Stem Cell Transplantation*
Humans
T-Lymphocytes / immunology
Transplantation Conditioning
Transplantation Immunology
Transplantation, Autologous
Transplantation, Heterologous
Chemical
Reg. No./Substance:
0/Autoantigens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gene therapy for immunologic tolerance: using bone marrow-derived cells to treat autoimmunity and he...
Next Document:  Autologous hematopoietic stem cell transplantation for systemic sclerosis.